Literature DB >> 12639582

Factors predicting choice of treatment for menorrhagia in gynaecology outpatient clinics.

Sirkku Vuorma1, Pekka Rissanen, Anna Mari Aalto, Erkki Kujansuu, Ritva Hurskainen, Juha Teperi.   

Abstract

The aim of this prospective study was to investigate factors predicting choice of treatment for excessive menstrual bleeding, with special emphasis on women's pre-treatment preference. A cohort of women with heavy menstruation and their treatment process in gynaecology outpatient clinics were followed-up for 1yr. A total of 383 35-54-yr-old women attending 14 Finnish hospitals participated. They completed a questionnaire before their first outpatient clinic visit, and postal follow-ups were conducted 3 and 12 months later. Information on treatment(s) during the follow-up was taken from medical records and questionnaires. The choice between hysterectomy and conservative treatments, and fulfillment of pre-treatment preference were the main outcome measures. During the 1-yr follow-up, 51% (n=196) of the women underwent hysterectomy and nine were still awaiting it, 12% (n=44) had a minor surgical procedure, 11% (n=41) had oral medication, 9% (n=33) used a hormonal intrauterine system, and nine women changed preventive method. Forty-two women (11%) reported having had no treatment. Data on previous treatments suggested that conservative treatment modalities were under-used. Most of the treatment decisions were made within the first 3-month period. Women's pre-treatment preference was the strongest predictor of chosen treatment. Unemployment, irregular periods and anxiety decreased the probability of a decision for hysterectomy, while pelvic pain and inconvenience due to bleeding increased it. The treatment plan accorded with pre-treatment preference in 72% of the women preferring hysterectomy and in 74% of those preferring a conservative option.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12639582     DOI: 10.1016/s0277-9536(02)00199-5

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  4 in total

Review 1.  Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-11-01

Review 2.  Digital health-enabled genomics: Opportunities and challenges.

Authors:  Yvonne Bombard; Geoffrey S Ginsburg; Amy C Sturm; Alicia Y Zhou; Amy A Lemke
Journal:  Am J Hum Genet       Date:  2022-07-07       Impact factor: 11.043

3.  Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system.

Authors:  Marko Elovainio; Juha Teperi; Anna-Mari Aalto; Seija Grenman; Aarre Kivelä; Erkki Kujansuu; Sirkku Vuorma; Merja Yliskoski; Jorma Paavonen; Ritva Hurskainen
Journal:  Int J Behav Med       Date:  2007

4.  Impact of patient information booklet on treatment decision--a randomized trial among women with heavy menstruation.

Authors:  Sirkku Vuorma; Pekka Rissanen; Anna-Mari Aalto; Ritva Hurskainen; Erkki Kujansuu; Juha Teperi
Journal:  Health Expect       Date:  2003-12       Impact factor: 3.377

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.